Clear and Present

Clear and Present


On the Biorisks of UAP

November 14, 2024

Following yesterday‘s congressional hearing on unidentified anomalous phenomena (UAP), IBR executive Director Dr. James Giordano discusses possible biological risks posed by UAP in both military and civilian contexts